These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3019376)

  • 21. Phenotypic and cytogenetic characteristics of a new Epstein-Barr virus negative cell line (SKW 4) derived from a B-cell lymphoma.
    Nilsson K; Klareskog L; Ralph P; Sundström C; Zech L
    Hematol Oncol; 1983; 1(4):277-95. PubMed ID: 6329938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Japanese Burkitt's lymphoma with t(2;8) and EBNA.
    Ishikura H; Matsuno Y; Okano M; Ishii Y; Tateno M; Abe K; Nakagawa M; Nakayama T; Aizawa M
    Acta Pathol Jpn; 1986 Jan; 36(1):133-42. PubMed ID: 3008496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus genome studies in Burkitt's and non-Burkitt's lymphomas in Uganda.
    Olweny CL; Atine I; Kaddu-Mukasa A; Owor R; Andersson-Anvret M; Klein G; Henle W; de-Thé G
    J Natl Cancer Inst; 1977 May; 58(5):1191-6. PubMed ID: 192894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
    Gavioli R; De Campos-Lima PO; Kurilla MG; Kieff E; Klein G; Masucci MG
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5862-6. PubMed ID: 1321426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.
    Kelly GL; Milner AE; Tierney RJ; Croom-Carter DS; Altmann M; Hammerschmidt W; Bell AI; Rickinson AB
    J Virol; 2005 Aug; 79(16):10709-17. PubMed ID: 16051863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endemic Burkitt's lymphoma: phenotypic analysis of tumor biopsy cells and of derived tumor cell lines.
    Rooney CM; Gregory CD; Rowe M; Finerty S; Edwards C; Rupani H; Rickinson AB
    J Natl Cancer Inst; 1986 Sep; 77(3):681-7. PubMed ID: 2943927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation.
    Cohen JH; Revillard JP; Magaud JP; Lenoir G; Vuillaume M; Manel AM; Vincent C; Bryon PA
    J Natl Cancer Inst; 1987 Feb; 78(2):235-42. PubMed ID: 3027441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
    Doyle MG; Crawford DH
    Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small noncleaved B cell Burkitt-like lymphoma with chromosome t(8;14) translocation and Epstein-Barr virus nuclear-associated antigen in a homosexual man with acquired immune deficiency syndrome.
    Petersen JM; Tubbs RR; Savage RA; Calabrese LC; Proffitt MR; Manolova Y; Manolov G; Shumaker A; Tatsumi E; McClain K
    Am J Med; 1985 Jan; 78(1):141-8. PubMed ID: 2981469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.
    Magrath IT; Pizzo PA; Whang-Peng J; Douglass EC; Alabaster O; Gerber P; Freeman CB; Novikovs L
    J Natl Cancer Inst; 1980 Mar; 64(3):465-76. PubMed ID: 6243721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Burkitt's lymphoma with 2/8 translocation: a case report with special reference to the clinical features.
    Abe R; Hayashi Y; Sampi K; Sakurai M
    Cancer Genet Cytogenet; 1982 Jun; 6(2):135-52. PubMed ID: 6286099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterization of the Epstein-Barr virus DNA in three new Burkitt's lymphoma-derived cell lines.
    Harris A; Walsh-Arrand JE; Crawford DH; Lenoir GM; Griffin BE
    Mol Biol Med; 1984 Apr; 2(2):135-50. PubMed ID: 6099862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.
    Menezes J; Leibold W; Klein G; Clements G
    Biomedicine; 1975 Jul; 22(4):276-84. PubMed ID: 179629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
    Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epstein-Barr virus associated Burkitt's lymphoma in a French child (author's transl)].
    Lenoir G; Philip T; Bornkamm GW; Gillet P; Bryon PA; Bouvier R; Dodat H; Doré JF; Brunat-Mentigny M; Hermier M
    Nouv Presse Med; 1979 Dec; 8(49):4031-3. PubMed ID: 93275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
    Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.
    Hochberg D; Middeldorp JM; Catalina M; Sullivan JL; Luzuriaga K; Thorley-Lawson DA
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):239-44. PubMed ID: 14688409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of a new Epstein-Barr virus nuclear antigen-positive B-cell line, BALL-2, with t(8;14) (q24;q32) chromosome abnormality from B-cell acute lymphoblastic leukemia, L2.
    Kubonishi I; Daibata M; Yano S; Isobe M; Kurosawa N; Nagumo H; Ogita Z; Ohyashiki JH; Toyama K; Miyoshi I
    Am J Hematol; 1991 Jul; 37(3):179-85. PubMed ID: 1650133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
    Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis.
    Gregory CD; Dive C; Henderson S; Smith CA; Williams GT; Gordon J; Rickinson AB
    Nature; 1991 Feb; 349(6310):612-4. PubMed ID: 1705663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.